Article
SARS-CoV-2 Mpro protease as a biomarker and therapeutic target in Long COVID: a real-world prospective cohort study
2026-02-19
Abstract excerpt
<title>Abstract</title> <p> Long COVID affects 400 million people worldwide, for whom predictive biomarkers and effective therapies are urgently needed. Herein, we investigate SARS-CoV-2 viral RNAs as candidate biomarkers and therapeutic targets. Combining whole blood digital transcriptomics and plasma proteomics, viral RNAs significantly correlated with platelet-expressed genes/proteins and complement/coagulati...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ac82d76f-c97f-53b6-9f04-95e3f89e05a5
- DOI
- 10.21203/rs.3.rs-7449833/v1
